The impact of the treatment of benign prostatic hyperplasia with lower urinary tract symptoms on quality of life, a scoping literature review aided by AI

被引:0
|
作者
Faraon, Bjarne [1 ,2 ]
Garces, Juan [1 ]
Ahmad, Sulaiman [1 ]
Mahmoud, Satanay [1 ]
Danzinger, Marc [1 ,2 ]
Shabsigh, Ridwan [1 ,2 ,3 ]
Mikelinich, Erik [4 ]
Carpo, Bea [4 ]
机构
[1] SBH Hlth Syst, Dept Surg, Bronx, NY 10457 USA
[2] CUNY, Sch Med, New York, NY 10031 USA
[3] Cornell Univ, Weill Cornell Med Coll, New York, NY 10065 USA
[4] NYIT Coll Osteopath Med, Glen Head, NY 11545 USA
关键词
Benign prostatic hyperplasia; Lower urinary tract symptoms; Quality of life; Intervention; TRANSURETHRAL RESECTION; PROSPECTIVE CROSSOVER; MANAGEMENT; EFFICACY; THERAPY; LASER; MEN;
D O I
10.22514/jomh.2024.104
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Benign prostatic hyperplasia (BPH) refers to a non-cancerous condition characterized by hyperplastic changes in stromal and epithelial cells. BPH can cause lower urinary tract symptoms (LUTS) that decrease quality of life (QoL). The International Prostate Symptom Score (IPSS) is a validated tool used to assess and guide the management of LUTS. This scoping review evaluated the difference in IPSS and QoL in patients with BPH and LUTS before and after medical or interventional treatment. A PubMed search was conducted using: (Benign prostatic hyperplasia OR lower urinary tract symptoms) AND (erectile dysfunction OR depression OR disability-adjusted life year OR quality of life), which yielded 7143 results over 10 years. With the use of artificial intelligence (AI), 31 articles were included in the study. Randomized control trials, prospective clinical trials, prospective and retrospective cohort studies, and meta-analyses were included. IPSS and IPSS-QoL measurements before and after intervention were required. Data was assessed in three categories "overall", "medical" and "interventional". Mean age, IPSS and QoL scores before and after intervention were calculated, as well as the Pearson correlation between baseline IPSS and QoL. Thirteen articles were categorized as medical while 18 were categorized as interventional. Pearson correlation between IPSS and QoL for overall, medical and interventional articles were r = 0.72, 0.79 and 0.36, respectively. There was an improvement in the QoL score by 1.28 points, 1.40 points, 2.49 points for overall, medical, and interventional groups, respectively. This study quantified the improvement in QoL after medical and interventional treatment of BPH. There is a strong correlation between the severity of BPH symptoms and the reduction of QoL. Improvement of BPH symptoms with medical and surgical treatments is associated with significant improvement in QoL.
引用
收藏
页码:8 / 14
页数:7
相关论文
共 50 条
  • [11] Treatment of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction
    Calogero, Aldo E.
    Burgio, Giovanni
    Condorelli, Rosita A.
    Cannarella, Rossella
    La Vignera, Sandro
    AGING MALE, 2018, 21 (04): : 272 - 280
  • [12] SILDENAFIL FOR TREATMENT OF LOWER URINARY TRACT SYMPTOMS SECONDARY TO BENIGN PROSTATIC HYPERPLASIA
    Ragheb, Ahmed M.
    Arafa, Mahmoud M.
    Moussa, Ayman S.
    Massoud, Amr M.
    JOURNAL OF UROLOGY, 2017, 197 (04): : E99 - E99
  • [13] Tadalafil for the Treatment of Lower Urinary Tract Symptoms in Men With Benign Prostatic Hyperplasia
    Rohrbough, C. R.
    Colgan, Bridget
    Gasser, Ollie
    AMERICAN FAMILY PHYSICIAN, 2024, 109 (01) : 83 - 84
  • [14] Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia
    Hwang, Eu Chang
    Gandhi, Shreyas
    Jung, Jae Hung
    Imamura, Mari
    Kim, Myung Ha
    Pang, Ran
    Dahm, Philipp
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (10):
  • [15] Silodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia
    Jung, Jae Hung
    Kim, Jiye
    MacDonald, Roderick
    Reddy, Balaji
    Kim, Myung Ha
    Dahm, Philipp
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (11):
  • [16] Tadalafil for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia
    Gonzalez, Ricardo R.
    Kaplan, Steven A.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2006, 2 (04) : 609 - 617
  • [17] Vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia
    Porst H.
    Sandner P.
    Ulbrich E.
    Current Urology Reports, 2008, 9 (4) : 295 - 301
  • [18] Medical Treatment of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia
    Michel, Martin
    de la Rosette, Jean
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (06) : 496 - 503
  • [19] Alfuzosin for the medical treatment of benign prostatic hyperplasia and lower urinary tract symptoms: a systematic review of the literature and narrative synthesis
    Mari, Andrea
    Antonelli, Alessandro
    Cindolo, Luca
    Fusco, Ferdinando
    Minervini, Andrea
    De Nunzio, Cosimo
    THERAPEUTIC ADVANCES IN UROLOGY, 2021, 13
  • [20] Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms Reply
    Sarma, Aruna V.
    Wei, John T.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (17): : 1668 - 1669